Dr. Li Qin, a statistician who has developed methods for studying long-term outcomes of cancer patients, has joined the Statistical Center for HIV/AIDS Research and Prevention (SCHARP). She began her new position Aug. 2.
Qin received a Ph.D. in Bioststatistics and Epidemiology from the University of Pennsylvania School of Medicine earlier this year. Her other research accomplishments include studies to identify genetic factors that contribute to risk of complex diseases.
SCHARP provides statistical and data management for several large-scale international AIDS prevention projects at Fred Hutchinson, including the HIV Vaccine Trials Network and the HIV Prevention Trials Network. In her new position with SCHARP, Qin will develop new statistical methods for the analysis of preventive HIV-vaccine trials, focusing on assessment of immune responses to vaccines over time and their association with the risk of HIV infection. She will also explore new applications in HIV-vaccine trials such as the integrated analysis of HIV sequence and immune-response data. In addition, Qin will serve as a lead statistician on clinical trials to test the safety of HIV-vaccine candidates and the vaccine's ability to provoke an immune response.
